510 results on '"Reyal F"'
Search Results
102. Impact du statut socioéconomique sur la gravité du diagnostic initial de cancer du sein
103. P4-09-13: External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Improvement Is Still Needed.
104. P4-09-01: Identification of Poor Prognosis T1T2N0 Luminal ERBB2-ve Breast Carcinomas.
105. P3-07-09: Prediction of Additional Nodal Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy: A New Nomogram Including HER2 Status.
106. PD02-08: Validation over Time of a Nomogram Predicting the Sentinel Node Positivity in Early Breast Carcinoma According to the Molecular Subtypes Classification.
107. Évaluation prospective et comparative de la toxicité de la chimioradiothérapie concomitante adjuvante après chimiothérapie néoadjuvante dans le cancer du sein
108. Prospective and Comparative Evaluation of the Toxicity of Adjuvant Concurrent Chemo-radiotherapy after Neoadjuvant Chemotherapy for Breast Cancer
109. Surgical resection of liver metastasis of breast cancer: A multidisciplinary approach—Study case-control.
110. Abstract P5-14-12: Management of Phyllodes Breast Tumours: A Review of 165 Cases
111. Abstract P5-13-11: Medico-Economic Assessment of the Genomic Grade Index on Adjuvant Treatment Strategy in Elston-Ellis Grade 2, Estrogen Receptor Positive, HER2 Negative, Node Negative, Small Size Breast Carcinomas
112. Abstract P3-10-09: Genomic Grade Index (GGI): Tumor Grading Performance and Prognostic Value Compared to Ki67 and Mitotic Index in Early Invasive Breast Cancer — A Reference Centre Experience
113. Abstract S6-7: Establishment and Characterization of Human Luminal Breast Cancer Xenografts
114. Abstract P5-14-18: Extended Pure Ductal Carcinoma In Situ of the Breast on Preoperative Biopsies. Prognostic Factors for Infiltrating Carcinoma and Lymph Node Involvement
115. Abstract P4-04-04: Polarity Abnormalities in Invasive Carcinomas of the Breast: Analysis of Invasive Micropapillary Carcinoma of the Breast
116. 276 Establishment and characterization of human luminal breast cancer xenografts
117. Locoregional Treatment for Breast Carcinoma after Hodgkin's Lymphoma: The Breast Conservation Option
118. Long-term Follow-up for Inflammatory Breast Cancer Patients: Institute Curie Experience
119. Le traitement conservateur dans la prise en charge loco-régionale du cancer du sein après maladie de Hodgkin
120. Étude de l’impact des inégalités sociales sur la gravité du cancer du sein lors du diagnostic, Île-de-France
121. Les sous-types moléculaires du cancer du sein. Apport des technologies à haut débit
122. 214 Molecular characterization of patient tumour-derived breast cancer xenografts shows a strong genomic and gene expression stability
123. Long-term results of a phase II trial of preoperative concurrent radiochemotherapy for breast cancers.
124. 451 Locoregional treatment of inflammatory breast cancer after neoadjuvant chemotherapy
125. 247 Is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?
126. 410 Lobular and luminal ductal invasive carcinoma of the breast – comparative molecular analysis
127. 183 A DNA signature to identify high-risk small node-negative breast cancer patients
128. 128 Locoregional recurrences in triple-negative, node-negative early stage breast cancer treated with breast-conserving treatment
129. Inflammatory Breast Cancer: What Should Be the Locoregional Treatment after Primary Chemotherapy?
130. Is Exclusive Radiotherapy an Option for Early Breast Cancers with Complete Clinical Response after Neoadjuvant Chemotherapy?
131. Transcriptomic Profiles and Circulating Tumor Cell Detection in Primary Breast Cancer.
132. Cancers du sein de petit stade : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?
133. Cancer du col et précarité, accès aux soins diagnostic et traitement
134. A comprehensive analysis of nine prognostic signatures reveals the high classification instability in breast cancer.
135. Identification of three-genomic regions prognostic signature in small node-negative breast carcinomas.
136. Oncoplasty for lateral breast cancers.
137. Portrait des altérations génétiques des carcinomes in situ de type canalaire du sein
138. Disseminated Bronchoalveolar Keratinocyte Plugs in Severe Neonatal Congenital Lamellar Ichthyosis
139. Monochorionic monoamnionic twins: vaginal delivery
140. Management of fetal thyroid goitres: a report of 11 cases in a single perinatal unit
141. Antenatal Diagnosis of Homozygous Alpha Thalassemia
142. p63/MT1-MMP axis is required for in situto invasive transition in basal-like breast cancer
143. Mesh erosion after anterior prosthetic reinforcement by vaginal route: risk factors and management.
144. Evidence-based medicine: principles and applications to obstetrics and to gynecologic surgery.
145. Quel est le temps nécessaire à un chirurgien pour modifier ses pratiques en chirurgie du sein ?
146. Prédiction de l'atteinte ganglionnaire axillaire résiduelle chez les patientes ayant un ganglion sentinelle positif : un nouveau nomogramme incluant HER2.
147. Cáncer de endometrio: diagnóstico, estudio preterapéutico, tratamiento y seguimiento
148. Antenatal diagnosis of Bart's hydrops fetalis [correction of homozygous alpha thalassemia]. A case report.
149. Facteurs décisifs de non-reconstruction chez 1 937 femmes après mastectomie totale ; information et choix des patientes.
150. Validation dans le temps d'un nomogramme prédictif de positivité du ganglion sentinelle axillaire en fonction des sous-types moléculaires de cancer du sein.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.